HealthQuad

Co-founders Abrar Mir and Ajay Mahipal serve as Managing Partners and lead the firm's investment committee. Both have backgrounds in Indian private equity and healthcare advisory, though the firm does not publicly detail the specific split of investment-committee authority between them. In practice, mid-market India funds of HealthQuad's size typically operate with a flat decision-making structure where both partners must approve any new commitment.

HealthQuad is an institutional private equity fund manager, not a family office. It raises capital from external limited partners — primarily development finance institutions and European family offices — rather than managing the wealth of a single family. Its legal structure is a Sebi-registered alternative investment fund under Indian securities regulations.

HealthQuad invests across early-stage venture, growth equity, and structured minority positions, though the majority of its deployment targets growth-stage companies with established revenue. The firm is willing to back pre-revenue medical device and health-tech startups from a seed-stage allocation, but its core check size and portfolio construction favor businesses that have already achieved clinical or operational scale in Indian Tier-1 and Tier-2 cities.

HealthQuad has not published a formal exclusions list, but its investment record suggests it avoids pharmaceutical drug discovery and large-scale hospital greenfield projects — two capital-intensive sub-sectors that demand timelines and risk profiles inconsistent with a mid-market private equity fund structure. The firm has also not disclosed any investments in health insurance or payer-side businesses.

HealthQuad relies on a proprietary network within India's single-specialty hospital and diagnostic-chain ecosystem — a fragmented market where most providers are founder-owned and do not transact through broad auction processes. The firm's narrow sector focus and development-finance LP relationships also generate inbound referrals from other impact-oriented investors and multilateral agencies active in Indian healthcare infrastructure.

HealthQuad exclusively makes direct investments in operating healthcare companies and health-tech platforms. The firm does not operate a fund-of-funds program, nor has it disclosed any LP commitments to other private equity or venture capital vehicles. Its mandate is to deploy capital into portfolio companies where the investment team can take board seats and influence operational direction.

There is no public record of HealthQuad being a subsidiary of, or affiliated with, a larger financial services group, hospital network, or industrial conglomerate. The firm appears to be an independent partnership launched by Mir and Mahipal, though the absence of detailed corporate filings makes complete independence difficult to confirm definitively.